Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Department of Radiology, Karolinska University Hospital, Stockholm, Sweden.
BMC Med Imaging. 2024 Jan 24;24(1):23. doi: 10.1186/s12880-024-01196-6.
Brain CT can be used to evaluate pediatric patients with suspicion of cerebral pathology when anesthetic and MRI resources are scarce. This study aimed to assess if pediatric patients referred for an elective brain CT could endure a diagnostic fast brain MRI without general anesthesia using a one-minute multi-contrast EPI-based sequence (EPIMix) with comparable diagnostic performance.
Pediatric patients referred for an elective brain CT between March 2019 and March 2020 were prospectively included and underwent EPIMix without general anesthesia in addition to CT. Three readers (R1-3) independently evaluated EPIMix and CT images on two separate occasions. The two main study outcomes were the tolerance to undergo an EPIMix scan without general anesthesia and its performance to classify a scan as normal or abnormal. Secondary outcomes were assessment of disease category, incidental findings, diagnostic image quality, diagnostic confidence, and image artifacts. Further, a side-by-side evaluation of EPIMix and CT was performed. The signal-to-noise ratio (SNR) was calculated for EPIMix on T1-weighted, T2-weighted, and ADC images. Descriptive statistics, Fisher's exact test, and Chi-squared test were used to compare the two imaging modalities.
EPIMix was well tolerated by all included patients (n = 15) aged 5-16 (mean 11, SD 3) years old. Thirteen cases on EPIMix and twelve cases on CT were classified as normal by all readers (R1-3), while two cases on EPIMix and three cases on CT were classified as abnormal by one reader (R1), (R1-3, p = 1.00). There was no evidence of a difference in diagnostic confidence, image quality, or the presence of motion artifacts between EPIMix and CT (R1-3, p ≥ 0.10). Side-by-side evaluation (R2 + R4 + R5) reviewed all scans as lacking significant pathological findings on EPIMix and CT images.
Full brain MRI-based EPIMix sequence was well tolerated without general anesthesia with a diagnostic performance comparable to CT in elective pediatric patients.
This study was approved by the Swedish Ethical Review Authority (ethical approval number/ID Ethical approval 2017/2424-31/1). This study was a clinical trial study, with study protocol published at ClinicalTrials.gov with Trial registration number NCT03847051, date of registration 18/02/2019.
当麻醉和 MRI 资源稀缺时,脑部 CT 可用于评估疑似脑部病变的儿科患者。本研究旨在评估是否可以使用基于一分钟多对比度 EPIMix 的快速脑部 MRI 序列(EPIMix)在不使用全身麻醉的情况下对接受择期脑部 CT 检查的儿科患者进行诊断,并且该序列具有可比的诊断性能。
2019 年 3 月至 2020 年 3 月期间,前瞻性纳入接受择期脑部 CT 检查的儿科患者,并在 CT 检查之外进行无全身麻醉的 EPIMix 检查。三位读者(R1-3)在两次独立的检查中分别独立评估 EPIMix 和 CT 图像。主要研究结果是:能否耐受无全身麻醉的 EPIMix 扫描;其对分类为正常或异常的扫描的性能。次要结果是评估疾病类别、偶然发现、诊断图像质量、诊断信心和图像伪影。此外,还对 EPIMix 和 CT 进行了并排评估。计算了 EPIMix 在 T1 加权、T2 加权和 ADC 图像上的信噪比(SNR)。使用描述性统计、Fisher 确切检验和卡方检验来比较两种成像方式。
15 名年龄 5-16 岁(平均 11 岁,标准差 3 岁)的患者均能耐受 EPIMix。所有读者(R1-3)均将 13 例 EPIMix 和 12 例 CT 分类为正常,而一位读者(R1)将 2 例 EPIMix 和 3 例 CT 分类为异常(R1-3,p=1.00)。EPIMix 和 CT 在诊断信心、图像质量或运动伪影的存在方面均无差异(R1-3,p≥0.10)。(R2+R4+R5)的并排评估认为 EPIMix 和 CT 图像上均没有明显的病理性发现。
在接受择期儿科患者中,无全身麻醉的全脑 MRI 基础 EPIMix 序列具有良好的耐受性,其诊断性能与 CT 相当。
本研究得到了瑞典伦理审查局的批准(伦理批准编号/ID 伦理批准 2017/2424-31/1)。这是一项临床试验研究,研究方案已在 ClinicalTrials.gov 上公布,注册号为 NCT03847051,注册日期为 2019 年 2 月 18 日。